PPLFF yields 5.11% · PFE yields 6.13%● Live data
📍 PPLFF pulled ahead of the other in Year 1
Combined, PPLFF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PPLFF + PFE for your $10,000?
PT Perusahaan Perkebunan London Sumatra Indonesia Tbk, together with its subsidiaries, engages in the plantation business in Indonesia. The company operates through Oil Palm Products, Rubber, Seeds, and Other Product segments. It offers crude palm oil, rubber, cocoa, tea, and oil palm seeds. The company also develops plantations on behalf of local smallholders. As of December 31, 2021, it had a total planted area of 114,111 hectares comprising 93,853 hectares of palm oil; 16,228 hectares of rubber; and 4,030 hectares of cocoa, tea, and other crops in North Sumatra, South Sumatra, East Kalimantan, North Sulawesi, South Sulawesi, and Java. The company is also involved in the research, processing, trading, marketing, industrial, and agency/representative activities; and invests in agricultural technology and cultivation, as well as agriculture, forestry, and fishery businesses. It exports its products. The company was founded in 1906 and is headquartered in Jakarta Selatan, Indonesia. PT Perusahaan Perkebunan London Sumatra Indonesia Tbk is a subsidiary of PT Salim Ivomas Pratama Tbk.
Full PPLFF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.